Innate Pharma SA Financial Overview
Innate Pharma SA's market cap is currently €148.96M. The company's EPS TTM is €-0.25; its P/E ratio is -2.94; Innate Pharma SA is scheduled to report earnings on September 17, 2025, and the estimated EPS forecast is €-0.12. See an overview of income statement, balance sheet, and cash flow financials.
